论文部分内容阅读
目的分析静脉注射心律平与西地兰转复阵发性室上性心动过速的治疗效果。方法将62例阵发性室上性心动过速患者随机分成心律平组和西地兰组,分别静脉注射心律平70~175 mg或西地兰0.4~1.0 mg,观察室上性心动过速的转复。结果心律平组31例,转复成功27例;西地兰组31例,转复成功19例,30 min转复成功率,两组比较差异有统计学意义(P<0.01)。转复成功时间,心律平组(47.2±29.3)min;西地兰组(68.6±39.8)min,两组比较差异有统计学意义(P<0.01)。结论在阵发性室上性心动过速复律中心律平组的成功率高于西地兰组。
Objective To analyze the curative effect of intravenous injection of ventricular arrhythmia and cedilanism on paroxysmal supraventricular tachycardia. Methods Sixty-two patients with paroxysmal supraventricular tachycardia were randomly divided into two groups: heart rhythm group and cedilanid group. The ventricular tachycardia level was 70-175 mg or 0.4-1.0 mg, respectively. The supraventricular tachycardia The recovery. Results In the 31 cases of heart rhythm group, 27 cases were successfully transplanted. In 31 cases of cedilanid group, 19 cases were successfully transplanted, and the successful rate was restored after 30 minutes. There was significant difference between the two groups (P <0.01). The successful recovery time was 47.2 ± 29.3 minutes in heart rhythm group and 68.6 ± 39.8 minutes in cedilanid group. There was significant difference between the two groups (P <0.01). Conclusions The success rate of ropivacaine in patients with paroxysmal supraventricular tachycardia is higher than that of cedilanid.